CRISPR AgBio: $1.2B Funding Fuels 2028 Market Boom
CRISPR gene-editing in agriculture gets $1.2B funding. Learn how commercialization moves from lab to market, tackling crop disease by 2028.
CRISPR gene-editing in agriculture gets $1.2B funding. Learn how commercialization moves from lab to market, tackling crop disease by 2028.
How will startups change drug delivery by 2026? AI, blockchain, and drones boost transparency, fight counterfeits, and expand access.
See how energy startups are driving change in 2026. Learn about advanced nuclear, DAC, and grid tech securing a $500M contract. Why it matters now.
CRISPR crops could reach $3B by 2030. See how gene editing fights climate change, boosts yields 15-20%, and improves food security.
CSL Seqirus enters the UK flu market in 2027. Learn how this new player could diversify vaccine supply and boost national resilience against influenza.
New startup tools use granular drug channel data to reshape pharma strategy. See how they improve market penetration and supply chains.
Small pharma's rise (70% of new drugs) creates skill gaps. See what talent is needed and how VC funding ($60B in 2025) fuels new roles.
Will new pharma startups bring down drug prices in 2026? Learn how companies like Valera Health aim to reduce costs for consumers.
CRISPR gene-editing in agriculture is set for $50B+ investment by 2030. Learn why it matters for crops, food, and future growth opportunities.
Fed rate hikes challenge Bitcoin startups. Learn how hedging, diversification, and strong cash flow protect solvency through 2026.